Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients: A 1-year Observational Study

Trial Profile

Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients: A 1-year Observational Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Dec 2016

At a glance

  • Drugs Everolimus (Primary)
  • Indications Liver transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Dec 2016 Status changed from recruiting to completed.
    • 11 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
    • 04 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top